RecruitingNot ApplicableNCT05194098

Using Electrophysiology to Index Non-invasive Brain Stimulation Effects on Reward System Functioning in Depression


Sponsor

San Francisco Veterans Affairs Medical Center

Enrollment

45 participants

Start Date

Oct 1, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Depression is a leading cause of morbidity and mortality, conferring substantial healthcare and societal costs. By studying methods to non-invasively target neural circuitry involved in reward responsivity, information generated by this project will improve understanding of the circuit alterations that underlie motivation and pleasure deficits in depression, and could also lead to the development of biologically-based markers of neurostimulation-based treatment response.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is using brain recordings (EEG) and non-invasive brain stimulation (TMS) to understand how the brain's reward system works differently in people with major depressive disorder (MDD). The findings could help improve future treatments for depression. **You may be eligible if...** - You are between 18 and 65 years old - You have normal or corrected-to-normal vision - (For participants with depression) You meet the clinical criteria for major depressive disorder and are on a stable psychiatric medication regimen for at least 1 month - You are able to attend in-person visits in San Francisco **You may NOT be eligible if...** - You have a history of neurological conditions such as seizures or significant head injury - You have a major medical condition that prevents safe participation in EEG, TMS, or MRI - You have substance dependence or current substance misuse - You are pregnant - You have claustrophobia - (For participants with MDD) You have a history of psychosis, bipolar disorder, or gambling disorder Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETMS: single session intermittent theta burst stimulation (iTBS) to dorsomedial prefrontal target in individuals with major depressive disorder, via MagVenture MagPro R30 device / Cool-DB80 A/P coil

Active Session: Single session of standard iTBS of 50Hz triplet bursts, 5 times each second with a 2 s on / 8 s off duty cycle for 600 pulses per hemisphere (1200 pulses total) will be applied for a total stimulation time of 6:40 minutes

DEVICESHAM (inactive) TMS stimulation

Sham neurostimulation (SHAM) entails use of the sham side of the D-B80 A/P placed over the same anatomical target, without any active stimulation.


Locations(1)

San Francisco VA Medical Center

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05194098


Related Trials